AbstractHIVHIV Prevention Summit 2021Development and implementation of a pre-exposure prophylaxis (PrEP) curriculum for pediatric residentsView Abstract
AbstractHIVHIV Prevention Summit 2021Assessing Knowledge About Pre-exposure Prophylaxis at a Higher Education Institution in The Western Cape, South Africa Using Limited Episodes of The MTV Shuga SeriesView Abstract
AbstractHIVHIV Prevention Summit 2021Post-Exposure Prophylaxis, Post-Violence Care and Ongoing HIV Risk: Missed Opportunities for HIV Prevention through Pre-Exposure Prophylaxis and Other InterventionsView Abstract
AbstractHIVHIV Prevention Summit 2021Intimate partner violence and gender-based violence among people living with HIV in southern NigeriaView Abstract
AbstractHIVHIV Prevention Summit 2021Characterizing Non-Occupational Post Exposure Prophylaxis for HIV in 5 Urban Health Centers of Kampala, Uganda: January 2016 - June 2019View Abstract
AbstractHIVHIV Prevention Summit 2021Uptake of HIV post-exposure prophylaxis, completion rates and self-reported reasons for non-completion among health care workers at Mbarara Regional Referral HospitalView Abstract
AbstractHIVHIV Prevention Summit 2021Socio-demographics of individuals initiated on HIV pre-exposure prophylaxis (PrEP) in NigeriaView Abstract
AbstractHIVHIV Prevention Summit 2021Community PrEP Service delivery for Female Sex Workers in GhanaView Abstract
AbstractHIVHIV Prevention Summit 2021Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis: A Real-World Evidence Analysis in the United StatesView Abstract
JMJean-Michel MolinaMD, PhDSlidesetHIVHIV Prevention Review Meeting 2021Recent Clinical Trials: What Does the Data Tell Us? - Jean-Michel Molina, MD, PhDView Slideset
RLRaphael LandovitzMD, MScSlidesetHIVHIV Prevention Review Meeting 2021Resistance, Breakthrough, Infections - Raphael Landovitz, MD, MScView Slideset
LCLarry CoreyMDSlidesetHIVHIV Prevention Review Meeting 2021HIV Vaccine Landscape - Larry Corey, MDView Slideset
